F-group (family)
223.3.1.3 Transpeptidase
Ligands and drugs
1,494
Member domains
1,150
with ligand contacts (≤ 4 Å)
77.0% of members
969
with DrugDomain annotations
64.9% of members
401
with a DrugBank compound
26.8% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 223.3.1.3 belongs to X-group 223 Profilin-like, which binds 8.8 ligand superclasses per 20 proteins, broader than 74% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02145 | 1BO | Butyl alcohol | 26 |
| DB08375 | CEF | (2R)-2-[(1R)-1-[[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-2-oxoethyl]-5-methylidene-2H-1,3-thiazine-4-carboxylic acid | 17 |
| DB00355 | AZR | Aztreonam | 6 |
| DB03530 | CAZ | Acylated ceftazidime | 6 |
| DB03658 | AXL | (2R,4S)-2-[(1R)-1-{[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino}-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid | 4 |
| DB09060 | FYG | Avibactam | 3 |
| DB09459 | TLA | L-tartaric acid | 3 |
| DB02122 | IAP | 4-iodo-acetamido phenylboronic acid | 2 |
| DB03450 | CEP | Cephalothin Group | 2 |
| DB04640 | BIH | Naphthalene-2,6-disulfonic acid | 2 |
| DB04740 | MX1 | Moxalactam (hydrolyzed) | 2 |
| DB06211 | O6P | Doripenem | 2 |
| DB08508 | S2D | N-BENZOYL-D-ALANINE | 2 |
| DB12107 | 4D6 | Vaborbactam | 2 |
| DB16338 | KJK | Taniborbactam | 2 |
| DB02175 | MLA | Malonic acid | 1 |
| DB02249 | ETX | 2-Ethoxyethanol | 1 |
| DB02536 | 3GR | D-glyceraldehyde | 1 |
| DB03309 | NHE | N-cyclohexyltaurine | 1 |
| DB03834 | TBE | (3S)-3-(dioxidosulfanyl)-N-[(1Z)-3-oxoprop-1-en-1-yl]-4-(1H-1,2,3-triazol-1-yl)-D-valine | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CL | CHLORIDE ION | 290 |
| NXL | (2S,5R)-1-formyl-5-[(sulfooxy)amino]piperidine-2-carboxamide | 61 |
| NAmetal | SODIUM ION | 42 |
| BR | BROMIDE ION | 30 |
| MER | (4R,5S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-5-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-4-methyl-4,5-dihydro-1H-pyrrole-2-carboxylic acid | 29 |
| 1BO | 1-BUTANOL | 28 |
| CDmetal | CADMIUM ION | 25 |
| Y33 | (5R)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-5-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-5-methyl-4,5-dihydro-1H-pyrrole-2-carboxylic acid | 25 |
| IM2 | (5R)-5-[(1S,2R)-1-formyl-2-hydroxypropyl]-3-[(2-{[(E)-iminomethyl]amino}ethyl)sulfanyl]-4,5-dihydro-1H-pyrrole-2-carboxylic acid | 23 |
| 4J6 | (4R,5S)-5-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-4-methyl-3-({(3S,5S)-5-[(sulfamoylamino)methyl]pyrrolidin-3-yl}sulfanyl)-4,5-dihydro-1H-pyrrole-2-carboxylic acid | 22 |
| ID1 | Imipenem | 22 |
| PNM | OPEN FORM - PENICILLIN G | 21 |
| CEF | CEFOTAXIME, C3' cleaved, open, bound form | 20 |
| COmetal | COBALT (II) ION | 20 |
| CAmetal | CALCIUM ION | 18 |
| ZNmetal | ZINC ION | 18 |
| IOD | IODIDE ION | 14 |
| 1S6 | (2R,4S)-5,5-dimethyl-2-[(1R)-1-{[(5-methyl-3-phenyl-1,2-oxazol-4-yl)carbonyl]amino}-2-oxoethyl]-1,3-thiazolidine-4-carboxylic acid | 13 |
| 2RG | (2S,3R,4S)-4-({(3S,5S)-5-[(3-carboxyphenyl)carbamoyl]pyrrolidin-3-yl}sulfanyl)-2-[(1S,2R)-1-formyl-2-hydroxypropyl]-3-methyl-3,4-dihydro-2H-pyrrole-5-carboxylic acid | 12 |
| CTJ | 1-({(2R)-2-[(1R)-1-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-2-oxoethyl]-4-carboxy-3,6-dihydro-2H-1,3-thiazin-5-yl}methyl)pyridinium | 12 |